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An analysis of the quality of cartilage studies- an update 
R. Jakobsen, L. Engebretsen, Norway 
Note to the reader: This article is an update to a previously published 
article (1), containing previously published results as well as new 
results. The reader is referred to the previously published paper for 
the details on materials and methods and for detailed discussion of 
older results.
Introduction
Surgical treatment for cartilage injury is of major interest to 
orthopaedic surgeons because most lesions of articular cartilage 
do not heal spontaneously and may predispose the joint to the 
subsequent development of secondary osteoarthritis.(2, 3) In 
a series of 993 knee arthoscopies performed because of pain, 
substantial cartilage lesions considered suitable for surgical 
treatment were detected in 6% of the patients.(4) Treatment for 
articular cartilage injuries includes the microfracture technique(5), 
autologous periosteal transplantation(6), autologous osteochondral 
transplantation(7), autologous chondrocyte implantation with(8, 9) 
and without(10) the assistance of various three dimensional matrices. 
In addition techniques utilizing allografts exist, though not widely 
used and therefore not a subject in this review. Much controversy is 
related to what is the best treatment option. Numerous published 
articles, in which the above treatment options were used, have 
described good or excellent results for a majority of patients, yet 
several authors have pointed out methodological weaknesses in the 
published studies. (11-13)
The purpose of this and the previously published article was to 
determine whether the optimistic reports in the literature are 
supported by sound methodological quality in the studies. Our main 
hypothesis was that the majority of the studies have methodological 
limitations that may limit the value of the reported results. We 
BEESFTTFEUIFNFUIPEPMPHJDBMMJNJUBUJPOTCZDBMDVMBUJPOBNPEJ¾FE
Coleman Methodology Score (CMS)(14) and a level-of-evidence 
rating.(15) In the previously published article we correlated this to 
the reported results to test whether studies of lesser methodological 
quality reported higher rates of success. In this article we have solely 
looked at the methodological quality of new studies published after 
our initial literature search.
We refer the reader to the previously published paper in The Journal 
of Bone and Joint Surgery American Volume, October, 2005 p. 2232(1) 
for a detailed materials and methods description. We used the exact 
same search strategy and selection criteria for this update and 
searched the Medline In-process and other Non-Indexed Citations, 
EMBASE and CINAHL using OVID. We also searched the Cochrane 
Central Register of Controlled Trials. All searches were performed 
BOE¾OJTIFEPO"QSJMUI
8F SFXJFWFE  BCTUSBDUT PG XIJDI FJHIUFFO ¾MMFE UIF TFMFDUJPO
criteria.
SPSS software (version 13.0.0; SPSS, Chicago, Illinois) was used to 
analyze the data.
*O PVS ¾STU BSUJDMF PO UIJT UPQJD XF JODMVEFE TJYUZPOF TUVEJFT
reporting on 3987 operations of which 260 were from randomized 
controlled trials. The average CMS was 43.5 (95% C.I., 40.3 to 46.7) 
XJUIFTQFDJBMMZ MPXTDPSFT JO¾WFDBUFHPSJFT 	
 UZQFPGTUVEZ 	

description of postoperative rehabilitation, (3) outcome criteria, (4) 
outcome assessment, and (5) subject selection process. At that time 
XF GPVOE UIJSUZ¾WF SFUSPTQFDUJWF TUVEJFT UXFOUZUXPQSPTQFDUJWF
studies and only four randomised controlled trials.
In this update eighteen studies(16-33) reported on 1003 operations 
(median 46) of which 195 were from randomised controlled trials 
and 116 from non-randomised controlled trials. The average CMS 
XBT	$*UP
XIJDIXBTBTUBUJTUJDBMTJHOJ¾DBOU
improvement (p<0.0001). However, methodological limitations 
were still frequently found in the above-mentioned categories. The 
average CMS for each criterion and the total CMS are given in Table I. 
The distribution of the studies with regard to type of treatment, type 
of study, and level-of-evidence rating is given in Table II.
*O PVS ¾STU SFWJFX XF BOBMZ[FE UIF PVUDPNF SFTVMUT XJUI SFTQFDU
UP UZQF PG UIFSBQZ CVU DPVME OPU ¾OE BOZ TJHOJ¾DBOU EJGGFSFODFT
between the reported outcomes (forty-seven studies; p = 0.11). 
Indeed, large variations in reported outcome were demonstrated 
within each treatment modality (Fig. 1). We found that the CMS 
correlated positively with the level-of-evidence rating (r = 0.668, p <
0.0001), but the variations within each level were large. In this update 
XF¾OEUIFTBNFUSFOE	'JH
CVU¾OEBOFWFOMBSHFSWBSJBUJPOTJO
the level-IV evidence.
"MTPJOUIF¾STUBSUJDMFXFJEFOUJ¾FETFWFSBMEPVCMFQVCMJDBUJPOT	
37), in addition to one article describing a group of patients(38) that 
may have been a subgroup of the patients included in a randomized 
trial.(34). We found no double publications in the update.
Interestingly we noticed that in one article patients received identical 
surgical treatment but were divided into two groups with different 
rehabilitation protocols(33) and another article reported on a new 
retrograde technique for treating tibial cartilage defects.(39) One 
article also reported on autologous chondrocyte implantation in 
combination with autologous osteochondral transplantation(29) 
and several papers reported on various types of matrix-assisted 
chondrocyte transplantation alone(8, 9) or compared to other 
treatments.(27)
Discussion
We refer the reader to the original article(1) for a detailed discussion 
on methods and previous results. This discussion only takes into 
BDDPVOU¾OEJOHTGSPNUIFOFXMZJODMVEFEBSUJDMFT
Research on the surgical treatment of cartilage injury has been 
extensive over the last two decades, and although numerous articles 
have been published reporting mostly good to excellent results, the 
methodology of the studies in general has been questioned.(11)
We previously showed that the majority of papers in this area had 
NFUIPEPMPHJDBM EF¾DJFODJFT 5IJT JT TUJMM UIF NBJO ¾OEJOH FWFO
UIPVHIJUJTFODPVSBHJOHUP¾OEBTJHOJ¾DBOUMZJNQSPWFE$.4
A total of 6 randomized controlled trials have been performed in 
cartilage treatment comparing autologous chondrocyte implantation 
and autologous ostechondral transplantation (mosaicplasty) 
(three studies)(24, 34, 40), autologous chondrocyte implantation 
and microfracture(41), autologous osteochondral transplantation 
(mosaicplasty) and microfracture(17), and autologous chondrocyte 
implantation and matrix-assisted autologous chondrocyte 
implantation(27). The CMS varied between 56 and 79. Four of 
UIFTF GPVOE OP TJHOJ¾DBOU EJGGFSFODF CFUXFFO USFBUNFOUT 0OF
well performed study (CMS = 79) found arthroscopic autologous 
osteochondral transplantation to be superior to microfracture(17). 
Another study found autologous chondrocyte implantation to be 
superior to autologous osteochondral transplantation (mosaicplasty), 
but were of lesser methodological quality (CMS = 56)(40).
As of today no treatment modality has emerged clearly superior to 
other modalities and it seems that several surgical methods provide 
a comparable good-to-excellent functional outcome at least in the 
POFUP¾WFZFBSQPTUPQFSBUJWFQFSJPE.PSFXFMMEFTJHOFEBOEXFMM
performed randomized controlled trials are needed to determine 
whether this is truly the case.
The increased focus on methodology in major journals by marking 
original articles with a level-of-evidence is highly appreciated. 
However, we would like to emphasize the fact that randomized 
DPOUSPMMFE USJBMT DBO IBWF TFSJPVT EFTJHO ¿BXT 	JF OPU VTJOH
independent reviewers, no statistical power analysis, not using 
an adequate randomization procedure, not accounting for eligible 
subjects not included in study), and therefore be rated as level-of-
evidence II. We would also like to draw the reader’s attention to 
the fact that several well-performed case series (level-IV evidence) 
score very well on the CMS. These studies largely take into 
consideration multiple aspects of good methodological quality 
TVDI BT JOEFQFOEFOU JOWFTUJHBUPS TVG¾DJFOU OVNCFS PG QBUJFOUT
well-described rehabilitation protocol, validated outcome measures 
and so forth, and are mainly lacking in not having a control group. 
We therefore recommend the reader to not entirely dismiss articles 
marked level-IV evidence, yet themselves assess the methodological 
quality of the paper when interpreting the results (for example using 
a grading system like the CMS).
0O UIF CBTJT PG PVS ¾OEJOHT JO UIJT VQEBUF XF NBJOUBJO UIF
recommendation to readers of cartilage studies to be cautious when 
JOUFSQSFUJOH SFTVMUT *O PVS ¾STU BSUJDMFXF QSPQPTFE UIF GPMMPXJOH
guidelines for future studies, and although methodology has 
JNQSPWFEXF¾OEJUXPSUIXIJMFUPSFQFBUUIFHVJEFMJOFTIFSF
4UVEJFTTIPVMECFQSPTQFDUJWFXJUIBDMFBSMZEF¾OFEIZQPUIFTJT
BOE POF DMFBSMZ EF¾OFE QSJNBSZ FOE QPJOU 5IFZ TIPVME CF
randomized controlled trials with an adequate randomization 
procedure and power analysis for the primary end point. Secondary 
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end points should only be used a supportive evidence to the primary 
hypothesis.
2. Patient inclusion and exclusion criteria should be clearly 
established and reported. The recruitment rate should be reported, 
and attempts should be made to account for eligible patients who 
are not included and those who are lost follow-up.
3. The outcome measure should be validated for use on patients 
with cartilage injuries.
4. Outcome assessment should be made by an independent 
investigator. The assessment should be in a written form and ideally 
be completed by the patient without investigator assistance.
5. The timing of the outcome assessment should be clearly stated. 
Results from various time-points after surgery should not be 
reported as one outcome. Assessments should be both clinical and 
functional. The minimum duration of follow-up should be more than 
twenty-four months.
6. Detailed rehabilitation protocols should be established and 
reported. Attempts should be made to monitor compliance. The 
protocols should be applied in a standardized manner to both 
patient cohorts.
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Table I:
Coleman Methodology Score for Studies on Surgical Repair of 
Cartilage (new studies)
Section score (maximum score) Mean Std. Deviation Range Median 
25th – 75th percentile
Part A
Study size, scoring (10) 6.1 3.1 0-10 7 4-8
Mean follow-up, scoring (5) 4.1 1.6 0-5 5 2-5
Number of surgical procedures (10) 10 0.0 10 10 10-10
Type of study(15) 5.8 6.2 0-15 5 0-15
Diagnostic certainty (5) 5.0 0.0 5 5 5-5
Description of surgical procedure (5) 4.8 0.6 3-5 5 3-5
Description of post-op. rehab. (10) 7.5 3.9 0-10 10 5-10
Part B
Outcome measures (10) 4.7 3.4 0-10 4 2-8
Outcome assessment (15) 4.8 4.5 0-15 5 0-8
Selection process (15) 3.6 2.3 0-5 5 0-5
Total part A (60) 43.2 9.0 27-57 40 37-52
Total part B (40) 13.1 6.2 2-22 13 9.0-20
Total CMS (100) 56.3 13.9 29-79 59 46-67
Table II: 
Distribution and Mean Coleman Methodology Score (CMS) of 
the studies According to Treatment, Type of Study, and Level of 
Evidence.
Number of studies Mean CMS (Range)
Treatmenta
Autologous chondrocyte implantationb 6 58.0 (34-75)
Autologous osteochondral transplantion 5 49.8 (29-64)
Microfracture 2 62.0 (50-62)
Periosteal transplantation 0 Not applicable
Otherc 1 46.0
Type of study
Retrospective 9 46.9 (29-60)
Prospective 6 62.5 (46-75)
RCT 3 72.3 (66-79)
JBJS Level of Evidence
I 1 79.0
II 2 69.0 (66-72)
III 2 46.0 (42-50)
IV 13 54.2 (29-75)
a. Controlled non-randomized and randomized trials not included.
b. Including matrix-assisted chondrocyte implantation.
c. Combination of autologous osteochondral transplantation with 
autologous chondrocyte implantation.
Fig. 1
Box plot of the outcome percentages in the good and excellent 
categories for each type of therapy as reported in forty-seven out 
PG UIF TJYUZPOF TUVEJFT JEFOUJ¾FE JO UIF ¾STU BSUJDMF 3BOEPNJ[FE
controlled trials are not shown. The difference in outcome between 
FBDIUZQFPGUIFSBQZXBTOPUGPVOEUPCFTJHOJ¾DBOU	,SVTLBM8BMMJT
test, p = 0.11)
